Presentation is loading. Please wait.

Presentation is loading. Please wait.

Bilobectomy for Lung Cancer: Analysis of Indications, Postoperative Results, and Long- Term Outcomes  Domenico Galetta, MD, PhD, Piergiorgio Solli, MD,

Published byวรพร ติณสูลานนท์ Modified over 5 years ago

Similar presentations

Presentation on theme: "Bilobectomy for Lung Cancer: Analysis of Indications, Postoperative Results, and Long- Term Outcomes  Domenico Galetta, MD, PhD, Piergiorgio Solli, MD,"— Presentation transcript:

1 Bilobectomy for Lung Cancer: Analysis of Indications, Postoperative Results, and Long- Term Outcomes 
Domenico Galetta, MD, PhD, Piergiorgio Solli, MD, PhD, Alessandro Borri, MD, Francesco Petrella, MD, Roberto Gasparri, MD, Daniela Brambilla, MS, Lorenzo Spaggiari, MD, PhD  The Annals of Thoracic Surgery  Volume 93, Issue 1, Pages (January 2012) DOI: /j.athoracsur Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Computed tomographic scans showing the radiologic conditions that lead the surgeon to perform a bilobectomy: (A) Presence of a tumor extended across the fissure; (B) neoplastic lymph nodes infiltrating the pulmonary artery (arrow); (C) bronchus involvement by the internal extension of the tumor and by external involvement by lymph nodes. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Overall 5-year (58%) survival curve including postoperative deaths (n = 146). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Survival curves at 5 years according to the stage of disease: stage I (n = 59), 70%; stage II (n = 52), 55%; stage III (n = 35), 40%. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

5 Fig 4 Survival curves at 5 years according to the N status; N0 69%, N1 56%, N2 40%. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

6 Fig 5 Survival curves at 5 years according to type of bilobectomy; upper and middle (UMB; n = 77), 43%; middle and lower (MLB; n = 69), 76.2%. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

7 Fig 6 Survival curves at 5 years according to the extension of resection: extended (n = 24), 27.2%; not extended (n = 122), 72.2%. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Bilobectomy for Lung Cancer: Analysis of Indications, Postoperative Results, and Long- Term Outcomes  Domenico Galetta, MD, PhD, Piergiorgio Solli, MD,"

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Sublobar Resection for Pulmonary Aspergilloma: A Safe Alternative to Lobectomy  Ping Yuan, MD, Jin-Lin Cao, MD, Sha Huang, MD, Chong Zhang, MD, Fei-Chao.

Sublobar Resection for Pulmonary Aspergilloma: A Safe Alternative to Lobectomy  Ping Yuan, MD, Jin-Lin Cao, MD, Sha Huang, MD, Chong Zhang, MD, Fei-Chao.
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.
Michael Kalina, DO, Frederick Giberson, MD 

Michael Kalina, DO, Frederick Giberson, MD 
Trevor Williams, MD, MPH, Brian C

Trevor Williams, MD, MPH, Brian C
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
The Effectiveness of Postoperative Radiotherapy in Patients With Completely Resected Thymoma: A Meta-Analysis  Dong Zhou, MD, Xu-Feng Deng, MD, Quan-Xing.

The Effectiveness of Postoperative Radiotherapy in Patients With Completely Resected Thymoma: A Meta-Analysis  Dong Zhou, MD, Xu-Feng Deng, MD, Quan-Xing.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,
Andranik Petrosyan, MD, Patrice Bergeron, MD 

Andranik Petrosyan, MD, Patrice Bergeron, MD 
Radio-Guided Localization and Resection of Small or Ill-Defined Pulmonary Lesions  Domenico Galetta, MD, PhD, Massimo Bellomi, MD, Chiara Grana, MD, Lorenzo.

Radio-Guided Localization and Resection of Small or Ill-Defined Pulmonary Lesions  Domenico Galetta, MD, PhD, Massimo Bellomi, MD, Chiara Grana, MD, Lorenzo.
Lung Cancer Staging: A Case for a New T Definition

Lung Cancer Staging: A Case for a New T Definition
Long-Term Outcome After Resection of Non-Small Cell Lung Cancer Invading the Thoracic Inlet  Stéphane Collaud, MD, MS, Tiago Machuca, MD, PhD, Olaf Mercier,

Long-Term Outcome After Resection of Non-Small Cell Lung Cancer Invading the Thoracic Inlet  Stéphane Collaud, MD, MS, Tiago Machuca, MD, PhD, Olaf Mercier,
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Cerebral Air Embolism as a Result of Inducing Pneumoperitoneum After Bilobectomy  Hak Young Rhee, MD, Dae Hyun Kim, MD, Young Tae Kwak, MD, Jae Woo Lee,

Cerebral Air Embolism as a Result of Inducing Pneumoperitoneum After Bilobectomy  Hak Young Rhee, MD, Dae Hyun Kim, MD, Young Tae Kwak, MD, Jae Woo Lee,
Lung Metastases From Colorectal Cancer: Analysis of Prognostic Factors in a Single Institution Study  Maria Giulia Zampino, MD, Patrick Maisonneuve, Eng,

Lung Metastases From Colorectal Cancer: Analysis of Prognostic Factors in a Single Institution Study  Maria Giulia Zampino, MD, Patrick Maisonneuve, Eng,

Similar presentations

Ads by Google